Clinical trials
Phase 2/3 trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
147 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 7 |
| 2005 | 4 |
| 2006 | 8 |
| 2007 | 7 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 10 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
| Recruiting | 26 |
| Terminated | 14 |
| Active, not recruiting | 13 |
| Unknown status | 12 |
| Enrolling by invitation | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 10 |
| Bristol-Myers Squibb | 7 |
| Janssen Research & Development, LLC | 7 |
| Pfizer | 6 |
| Umeå University | 6 |
| Merck Sharp & Dohme LLC | 4 |
| Baxalta now part of Shire | 3 |
| Region Skane | 3 |
| Sanofi | 3 |
| AbbVie | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 5 |
| Rhinitis, Allergic | 4 |
| Alzheimer Disease | 3 |
| Amyloid Neuropathies, Familial | 3 |
| Amyloidosis | 3 |
| COVID-19 | 3 |
| Colorectal Neoplasms | 3 |
| Hemophilia A | 3 |
| Mucopolysaccharidosis II | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 1 to 25 of 147. Each trial links to its page on Pharma Observatory.
47 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.